StreetInsider.com News Articles

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

TUCSON, Ariz., June 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the world’s first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced that SynCardia researchers will present new preclinical data from the Company's next generation Emperor Total Artificial Heart program and new clinical outcomes research involving patients supported with the SynCardia Total Artificial Heart at the American Society for Artificial Internal Organs (ASAIO) 2026 Annual Conference, taking place June 18-21, 2026, in

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Tue, 16 Jun 2026 08:00:00 -0400

Form PRE 14A Picard Medical, Inc. For: Jul 17

Mon, 15 Jun 2026 06:09:00 -0400

si-local-file:///var/storage/secattach/20260615/26643752.html

Form PRE 14A Picard Medical, Inc. For: Jul 17

Mon, 15 Jun 2026 06:09:00 -0400

si-local-file:///var/storage/secattach/20260615/26643752.html

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

Thu, 11 Jun 2026 06:00:00 -0400

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News:

The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.47 per common share, payable on July 20, 2026, to shareholders of record as of June 25, 2026. The ex-dividend date is June 25, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend.

Philip Morris International: A Global Smoke-Free Champion
Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

Thu, 11 Jun 2026 06:00:00 -0400

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News:

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

Thu, 11 Jun 2026 06:00:00 -0400

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News:

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

Thu, 11 Jun 2026 06:00:00 -0400

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News:

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

Thu, 11 Jun 2026 06:00:00 -0400

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News:

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

Thu, 11 Jun 2026 06:00:00 -0400

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News:

Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

Thu, 11 Jun 2026 06:00:00 -0400

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News: